Antonio Di Muzio

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)

B. Castagneto, Mario Botta, Enrico Aitini et al. · Annals of Oncology · 2007 · 138 citations · Full text

Malignant Pleural Mesothelioma, Medicine, Phase Ii Study +5

Large-Scale Population Analysis Challenges the Current Criteria for the Molecular Diagnosis of Fascioscapulohumeral Muscular Dystrophy

Isabella Scionti, Francesca Gabriella Greco, Giulia Ricci et al. · The American Journal of Human Genetics · 2012 · 123 citations · Full text

Genetic Analysis, Molecular Diagnosis, Mendelian Disorder +12

Large scale genotype–phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy

Giulia Ricci, Isabella Scionti, Francesco Sera et al. · Brain · 2013 · 119 citations · Full text

Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA)

Valentina Gatta, Oronzo Scarciolla, Anna Rita Gaspari et al. · Human Genetics · 2005 · 113 citations

Carrier Females, Mendelian Disorder, Dmd Gene +9